Allopurinol use is associated with greater functional gains in older rehabilitation patients

Age and Ageing

Volumn 42, Issue 3, 2013, Pages 400-404

  Beveridge, Louise A ^a,b   Ramage, Lynn ^a   Mcmurdo, Marion E T ^b   George, Jacob ^b   Witham, Miles D ^b  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Allopurinol; Older people; Oxidative stress; Rehabilitation

Indexed keywords

ALLOPURINOL;

AGED; ARTICLE; BARTHEL SCORE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG USE; FEMALE; FRACTURE; FUNCTIONAL ASSESSMENT; GERIATRIC REHABILITATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL RATE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALLOPURINOL; ANTIOXIDANTS; ENZYME INHIBITORS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT DISCHARGE; PROPORTIONAL HAZARDS MODELS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOPENIA; SCOTLAND; TIME FACTORS; TREATMENT OUTCOME; XANTHINE OXIDASE;

EID: 84877075259     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/aft046     Document Type: Article

References (13)

1. George J, Carr E, Davies J et al. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006; 114: 2508-16.
2. Khan F, George J, Wong K et al. Allopurinol treatment reduces arterial wave reflection in stroke survivors. Cardiovasc Ther 2008; 26: 247-52.
3. Butler R, Morris AD, Belch J et al. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000; 35: 746-51.
4. Doehner W, Schoene N, Rauchhaus M et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002; 105: 2619-24.
5. Rajendra NS, Ireland S, George J et al. Mechanistic insights into the therapeutic use of high dose allopurinol in angina pectoris. J Am Coll Cardiol 2010; 58: 820-8.
6. Noman A, Ang DS, Ogston S et al. Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet 2010; 375: 2161-7.
7. Cross CE, Halliwell B, Borish ET et al. Oxygen radicals and human disease. Ann Intern Med 1987; 107: 526-45.
8. Meng SJ, Yu LJ. Oxidative stress, molecular inflammation and sarcopenia. Int J Mol Sci 2010; 11: 1509-26.
9. Witham MD, Ramage L, Burns SL et al. Trends in function and postdischarge mortality in a medicine for the elderly rehabilitation centre over a 10-year period. Arch Phys Med Rehabil 2011; 92: 1288-92.
10. Wade DT, Collin C. The Barthel ADL Index: a standard measure of physical disability? Int Disabil Stud 1988; 10: 64-7.
11. Sumukadas D, Witham MD, Struthers AD, McMurdo MET. Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial. CMAJ 2007; 177: 867-74.
12. Lynch JE, Henderson NR, Ramage L et al. Association between statin medication use and improved outcomes during inpatient rehabilitation in older people. Age Ageing 2012; 41: 260-2.
13. Hellsten Y, Frandsen U, Ørthenblad N et al. Xanthine oxidase in human skeletal muscle following eccentric exercise: a role in inflammation. J Physiol 1997; 498: 8.